Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.25
Bid: 8.00
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 0.50 (6.25%)
Open: 8.25
High: 8.25
Low: 8.25
Prev. Close: 8.25
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

2 Oct 2008 09:37

2 October 2008 Totally plc (`'Totally'' or `'the Company'') Issue of warrants

In the announcement made on 1 September 2008 relating to the disposal of a trading subsidiary, the Company announced that The Zvhil-Mezbuz Rebbe, Grand Rabbi Y.A. Korff of Boston ("the Rebbe") would be released from his obligations under the guarantee to Bank Hapoalim to support the Company's banking facility. The guarantee to Bank Hapoalim to support the extended credit facility of ⣠700,000 for the Company would be provided by Leo Noĩ, a third party shareholder, and Dr Michael Sinclair, Non-Executive Chairman (together the "Guarantors").

In addition, the Company stated that it was the intention of the Board to issue warrants to Leo Noĩ and Dr Sinclair as guarantors of the facility in the near future in recognition of the increase in their personal guarantees.

Following approval of the resolutions at the general meeting of the Company held on 25 September 2008 and in accordance with the terms of the Jewish Advocate Publishing Corporation share purchase agreement, the Company has today cancelled warrants to subscribe for 4,394,350 ordinary shares which had been issued to the Rebbe.

Furthermore, owing to the exercise price of all of the warrants previously issued in relation to the personal guarantees to Bank Hapoalim to support the Company's overdraft facility being significantly above the current share price, the Company has agreed to cancel all the warrants issued to Dr Sinclair and Leo Noĩ and to replace the cancelled warrants, by issuing 35,000,000 warrants to each of Dr Sinclair and Leo Noĩ in recognition of the fact that the Guarantors have continued to provide personal guarantees to Bank Hapoalim.

The warrants are exercisable immediately from the date of issue for a period of five years at an exercise price of 1 penny per share, being the nominal value of the Company's ordinary shares, which is a premium of 132.5 per cent over the closing middle-market price on 1 October 2008.

At the date of this announcement, Dr Sinclair holds 14,509,791 ordinary shares and warrants over 35,000,000 ordinary shares exercisable at one penny per share. Mr Noĩ currently holds 6,666,666 ordinary shares and warrants over 35,000,000 ordinary shares exercisable at one penny per share.

Following the issue of the new warrants detailed above there will be warrants outstanding over 90,123,013 Ordinary Shares, equivalent to 98.02 per cent. of the issued voting share capital of the Company, which are exercisable at exercise prices ranging from 1 to 5 pence per share.

At the date of this announcement the Company has 91,947,934 ordinary voting shares in issue.

If Dr Sinclair were to exercise his warrants and no other shares in the Company were to be issued, Dr Sinclair would hold 49,509,791 ordinary shares, representing 39.00 per cent. of the then enlarged issued share capital. If Leo Noĩ were to exercise his warrants and no other shares in the Company were issued, Mr Noĩ would hold 41,666,666 ordinary shares, equivalent to 32.82 per cent. of the then enlarged issued share capital. In addition, if both Dr Sinclair and Mr Noĩ were to exercise their warrants and no other shares in the Company be issued, between them they would hold 91,176,457 ordinary shares, equivalent to 56.30 per cent. of the then enlarged issued share capital.

Were either of Dr Sinclair or Mr Noĩ to exercise their warrants, to such an extent that individually they would hold 30 per cent. or more of the then issued share capital, they would first need to be granted a waiver of Rule 9 of the Takeover Code, which would need to be approved by shareholders of the Company at a general meeting.

Under the AIM Rules, the issue of the warrants is classified as a related party transaction. The directors, other than Dr Michael Sinclair, who is interested in the warrant issue, (the "Independent Directors") who have consulted with John East & Partners Limited, consider the terms of the warrant issue to be fair and reasonable insofar as the shareholders are concerned. In advising the Independent Directors, John East & Partners Limited has relied upon their commercial assessment.

For further information:

Totally Plc www.totallyplc.com T: 020 7692 6929

Daniel Assor CEO John East & Partners Limited T: 020 7628 2200

David Worlidge / Simon Clements HB Corporate T: 020 7510 8654

Luke Cairns

vendor
Date   Source Headline
18th Feb 20197:00 amRNSHolding(s) in Company
24th Jan 20191:55 pmRNSHolding(s) in Company
18th Jan 20199:15 amRNSChange of Registered Office
7th Dec 20187:00 amRNSVocare secures new contract worth c.£1.2m
19th Nov 20184:20 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSCQC upgrade service ratings in Staffordshire
5th Nov 20187:00 amRNSInterim results
2nd Nov 20187:00 amRNSChange of Broker
30th Oct 201812:50 pmRNSHolding(s) in Company
24th Oct 20187:00 amRNSTrading Statement
23rd Oct 20186:28 pmRNSHolding(s) in Company
17th Oct 20187:00 amRNSVocare awarded £3.3m contract extension
19th Sep 20184:30 pmRNSHolding(s) in Company
19th Sep 20187:00 amRNSAbout Health awarded contract valued up to £3.6m
10th Sep 201812:01 pmRNSResult of AGM
3rd Aug 201810:24 amRNSHolding(s) in Company
3rd Aug 20189:00 amRNSPrice Monitoring Extension
25th Jul 20187:00 amRNSPosting of Annual Report and Notice of AGM
20th Jul 20187:00 amRNSAbout Health: new/extended contracts worth c.£1.7m
19th Jul 20183:03 pmRNSHolding(s) in Company
16th Jul 20187:00 amRNSAbout Health awarded contract worth up to £3.2m
10th Jul 20187:00 amRNSFinal Results
24th May 20185:29 pmRNSHolding(s) in Company
21st May 20185:04 pmRNSHolding(s) in Company
17th May 20187:00 amRNSVocare awarded contract extension worth £770,000
11th May 20187:00 amRNSVocare confirms £1.2m per annum contract renewal
8th May 201810:38 amRNSResult of General Meeting
4th May 20185:01 pmRNSHolding(s) in Company
4th May 20185:00 pmRNSHolding(s) in Company
26th Apr 20183:13 pmRNSHolding(s) in Company
24th Apr 20183:00 pmRNSHolding(s) in Company
23rd Apr 20184:32 pmRNSHolding(s) in Company
23rd Apr 201811:33 amRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSNotice of GM
13th Apr 20187:00 amRNSVocare secures c. £5m contract in the North West
3rd Apr 20183:40 pmRNSHolding(s) in Company
28th Mar 20187:00 amRNSInterim results
15th Mar 20187:00 amRNSVocare awarded contract extensions worth c. £4.1m
14th Mar 20183:26 pmRNSVocare agrees to conclude Somerset GP OOH Service
22nd Feb 20181:33 pmRNSHolding(s) in Company
14th Feb 20183:00 pmRNSDirector/PDMR Shareholding
31st Jan 20184:07 pmRNSGrant of Options
12th Jan 20185:05 pmRNSPDMR Shareholding
9th Jan 20187:01 amRNSBusiness update
9th Jan 20187:00 amRNSVocare awarded contract: South Staffordshire CCGs
2nd Jan 20183:44 pmRNSGrant of Options under SAYE Option Scheme
18th Dec 20177:00 amRNSAndy Gregory appointed Managing Director, Vocare
4th Dec 20177:00 amRNSBoard appointment - Clinical Quality Director
30th Nov 20177:00 amRNSTrading Update
29th Nov 201711:15 amRNSChange of accounting year end

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.